New medicines that hit the market in the 1990s and 2000s have made the difference between life and death for many people affected by HIV and AIDS. HIV medicines like nucleoside reverse transcriptase inhibitors, or NRTIs, have turned a virus whose diagnosis once meant certain death into a manageable chronic condition.
In 2004, a new drug came to market that could help treat HIV-positive adults in combination with other HIV medications, like NRTIs. The drug, called Truvada PrEP with TDF, is now approved to protect HIV-negative individuals from ever contracting the virus and was recently approved to protect teens who test negative for HIV. When used as protection instead of treatment, it is called Truvada for pre-exposure prophylaxis, or PrEP.
Though the drug has helped treat and protected some people from HIV infection, it has been potentially harmful to others. Truvada with TDF, like other HIV medicines, can put some people at an increased risk for dangerous side effects, including lactic acidosis, which can be deadly. It’s essential for people looking to take Truvada with TDF, or other similar medications, for HIV prevention to understand all of the risks associated with the drugs so they can make informed decisions when talking with their healthcare provider.
People who began treatment with this drug and developed severe conditions like lactic acidosis are now filing lawsuits against the drug’s manufacturer, Gilead Sciences Inc. The lawsuits accuse Gilead of manufacturing a defective product and not informing the public of all the potential risks associated with their prescription. If you took Truvada PrEP with TDF and developed lactic acidosis or severe kidney or liver problems, you may qualify for a Truvada lawsuit.